Different HBsAg decline during 3 years of treatment with entecavir in patients affected by chronic hepatitis B HBeAgnegative and HBV genotypes A, D and E

Di Perri, Giovanni; Boglione, Lucio

Back to search

Università degli Studi di Torino

Different HBsAg decline during 3 years of treatment with entecavir in patients affected by chronic hepatitis B HBeAgnegative and HBV genotypes A, D and E

dc:creator Di Perri, Giovanni; Boglione, Lucio

dc:date2018

Degree

thesis:*

Grantor dc:publisher: Università degli Studi di Torino
Year dc:date: 2018

Author and committee

dc:creator, dc:contributor.*

Authors dc:creator: Di Perri, Giovanni
Boglione, Lucio

Subjects

dc:subject × 1

Settore MED/17 - Malattie Infettive

Rights

dc:rights

Statement dc:rights: info:eu-repo/semantics/openAccess
Language dc:language: eng

Identifiers

dc:identifier.*

Handle dc:identifier: https://hdl.handle.net/2318/1995288
OAI identifier oai:identifier: oai:iris.unito.it:2318/1995288

Chain of custody

source

Harvested from: Università di Torino
Base URL: iris.unito.it/oai/driver
Last updated: 2026-07-24
Source record: OAI-PMH GetRecord

related terms

citation

Di Perri, Giovanni; Boglione, Lucio. Different HBsAg decline during 3 years of treatment with entecavir in patients affected by chronic hepatitis B HBeAgnegative and HBV genotypes A, D and E. Università degli Studi di Torino, 2018. https://hdl.handle.net/2318/1995288

Different HBsAg decline during 3 years of treatment with entecavir in patients affected by chronic hepatitis B HBeAgnegative and HBV genotypes A, D and E

Degree

Author and committee

Subjects

Rights

Identifiers

Chain of custody

More from Università di Torino